The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner

Oncogene

Volumn 34, Issue 32, 2015, Pages 4190-4198

  Shanzer, M ^a   Ricardo Lax, I ^a   Keshet, R ^a   Reuven, N ^a   Shaul, Y ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

LONG ACTING THYROID STIMULATOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; VIRUS MIDDLE T ANTIGEN; HIPPO PROTEIN, HUMAN; LATS1 PROTEIN, HUMAN; PHOSPHOPROTEIN; PROTEIN KINASE P60; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VIRUS T ANTIGEN; WWTR1 PROTEIN, HUMAN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL NUCLEUS; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EMBRYO; HUMAN; HUMAN CELL; NONHUMAN; POLYOMAVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; VIRUS CARCINOGENESIS; ANIMAL; CELL LINE; CONFOCAL MICROSCOPY; GENETICS; HEK293 CELL LINE; IMMUNOBLOTTING; METABOLISM; MUTATION; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

POLYOMAVIRUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROSCOPY, CONFOCAL; MUTATION; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RATS; SIGNAL TRANSDUCTION;

EID: 84938955604     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.347     Document Type: Article

References (40)

1. O'Shea CC. DNA tumor viruses - the spies who lyse us. Curr Opin Genet Dev 2005; 15: 18-26.
2. Helt A-M, Galloway DA. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 2003; 24: 159-169.
3. Fluck MM, Schaffhausen BS. Lessons in signaling and tumorigenesis from polyomavirus middle T antigen. Microbiol Mol Biol Rev 2009; 73: 542-563.
4. Treisman R, Novak U, Favaloro J, Kamen R. Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature 1981; 292: 595-600.
5. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992; 12: 954-961.
6. Gottlieb KA, Villarreal LP. Natural biology of polyomavirus middle T antigen. Microbiol Mol Biol Rev 2001; 65: 288-318.
7. Courtneidge SA, Smith AE. The complex of polyoma virus middle-T antigen and pp60c-src. EMBO J 1984; 3: 585-591.
8. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 1994; 8: 23-32.
9. Harvey R, Oostra BA, Belsham GJ, Gillett P, Smith AE. An antibody to a synthetic peptide recognizes polyomavirus middle-T antigen and reveals multiple in vitro tyrosine phosphorylation sites. Mol Cell Biol 1984; 4: 1334-1342.
10. Kamps MP, Buss JE, Sefton BM. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation. Proc Natl Acad Sci USA 1985; 82: 4625-4628.
11. Schaffhausen B, Benjamin TL. Comparison of phosphorylation of two polyoma virus middle T antigens in vivo and in vitro. J Virol 1981; 40: 184-196.
12. Zhao B, Wei X, Li W. Inactivation of Yap oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007; 21: 2747-2761.
13. Zeng Q, Hong W. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell 2008; 13: 188-192.
14. Hao Y, Chun A, Cheung K, Rashidi B, Yang X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 2007; 283: 5496-5509.
15. Liu C-Y, Zha Z-Y, Zhou X, Zhang H, Huang W, Zhao D et al. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCFβ-TrCP E3 ligase. J Biol Chem 2010; 285: 37159-37169.
16. Zhao B, Ye X, Yu J, Li L, Li W, Li S et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 2008; 22: 1962-1971.
17. Mahoney WMJ, Hong J-H, Yaffe MB, Farrance IKG. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J 2005; 388: 217-225.
18. Lei Q-Y, Zhang H, Zhao B, Zha Z-Y, Bai F, Pei X-H et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Molec Cell Biol 2008; 28: 2426-2436.
19. Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M et al. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 2000; 19: 6778-6791.
20. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 2010; 24: 72-85.
21. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA et al. Elucidation of a universal size-control mechanism in drosophila and mammals. Cell 2007; 130: 1120-1133.
22. Halder G, Johnson RL. Hippo signaling: growth control and beyond. Development 2011; 138: 9-22.
23. Tian Y, Li D, Dahl J, You J, Benjamin T. Identification of TAZ as a Binding Partner of the Polyomavirus T Antigens. J Virol 2004; 77: 12657-12664.
24. Glenn GM, Eckhart W. Amino-terminal regions of polyomavirus middle T antigen are required for interactions with protein phosphatase 2A. J Virol 1995; 69: 3729-3736.
25. Cook DN, Hassell JA. The amino terminus of polyomavirus middle T antigen is required for transformation. J Virol 1990; 64: 1879-1887.
26. Campbell KS, Auger KR, Hemmings BA, Roberts TM, Pallas DC. Identification of regions in polyomavirus middle T and small t antigens important for association with protein phosphatase 2A. J Virol 1995; 69: 3721-3728.
27. Tsutsumi R, Masoudi M, Takahashi A, Fujii Y, Hayashi T, Kikuchi I et al. YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function. Dev Cell 2013; 26: 658-665.
28. Yang Y, Jiang B, Huo Y, Primo L, Dahl JS, Benjamin TL et al. Shp2 suppresses PyMTinduced transformation in mouse fibroblasts by inhibiting Stat3 activity. Virology 2011; 409: 204-210.
29. Ota M, Sasaki H. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 2008; 135: 4059-4069.
30. Zhao B, Kim J, Ye X, Lai ZC, Guan KL. Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Cancer Res 2009; 69: 1089-1098.
31. Schaffhausen BS, Roberts TM. Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer. Virology 2009; 384: 304-316.
32. Dilworth SM. Polyoma virus middle T antigen: meddler or mimic? Trends Microbiol 1995; 3: 31-35.
33. Raptis L, Lamfrom H, Benjamin TL. Regulation of cellular phenotype and expression of polyomavirus middle T antigen in rat fibroblasts. Mol Cell Biol 1985; 5: 2476-2486.
34. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the Hippo pathway. Mol Cell Biol 2008; 28: 2426-2436.
35. Primo L, Roca C, Ferrandi C, Lanfrancone L, Bussolino F. Human endothelial cells expressing polyoma middle T induce tumors. Oncogene 2000; 19: 3632-3641.
36. Williams RL, Risau W, Zerwes HG, Drexler H, Aguzzi A, Wagner EF. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell 1989; 57: 1053-1063.
37. Grazia Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 2003; 161: 793-804.
38. Levy D, Adamovich Y, Reuven N, Shaul Y. The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73. Cell Death Differ 2007; 14: 743-751.
39. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990; 18: 3587-3596.
40. Carey MF, Peterson CL, Smale ST. Dignam and Roeder nuclear extract preparation. Cold Spring Harb Protoc 2009; 2009: pdb prot5330.